<Suppliers Price>

AT-007

Names

[ CAS No. ]:
2170729-29-8

[ Name ]:
AT-007

Biological Activity

[Description]:

AT-007 is an orally active central nervous system (CNS) penetrant Aldose Reductase inhibitor for treatment of Galactosemia with an IC50 value of 100 pM[1][2].

[Target]

IC50: 100 pM (Aldose Reductase)[2]


[References]

[1]. Maeve Conneighton, et al. Applied Therapeutics Announces Initiation of Phase 1/2 Study of AT-007 in Galactosemia.

[2]. UNITED STATES SECURITIES AND EXCHANGE COMMISSION. APPLIED THERAPEUTICS, INC.

Chemical & Physical Properties

[ Molecular Formula ]:
C17H10F3N3O3S2

[ Molecular Weight ]:
425.40

Related Compounds